Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism

Mario Berger; Henriette Moscatelli; Bettina Kulle; Beate Luxembourg; Katja Blouin; Michael Spannagl; Edelgard Lindhoff-Last; Christian M. Schambeck

doi:10.1160/TH08-01-0059

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2008; 99(05): 905-908
DOI: 10.1160/TH08-01-0059

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolism

Autor*innen

Mario Berger^*

¹Medical Department, University of Oslo, Oslo, Norway

²Institute of Clinical Biochemistry and Pathobiochemistry – Central Laboratory, University of Würzburg, Würzburg, Germany
Henriette Moscatelli^*

¹Medical Department, University of Oslo, Oslo, Norway
Bettina Kulle

³Department of Biostatistics and Department of Mathematics, University of Oslo, Oslo, Norway
Beate Luxembourg

⁴Medical Department, University of Frankfurt, Frankfurt, Germany
Katja Blouin

¹Medical Department, University of Oslo, Oslo, Norway

²Institute of Clinical Biochemistry and Pathobiochemistry – Central Laboratory, University of Würzburg, Würzburg, Germany
Michael Spannagl

⁵Medical Department, University of Munich, Munich, Germany
Edelgard Lindhoff-Last

⁴Medical Department, University of Frankfurt, Frankfurt, Germany
Christian M. Schambeck

⁶Institute of Clinical Chemistry – Campus Kiel, University Hospital Schleswig-Holstein, Kiel, Germany

Abstract

Summary

A suggestive locus on chromosome 8 could be shown to be associated with familial high factor VIII (FVIII) levels in venous thromboembolism. The ADAMDEC 1 gene is a candidate expressing an ectodomain sheddase. However, the ectodomain of the clearance receptor for FVIII, the low-density lipoprotein receptor-related protein (LRP), is subject to proteolysis by metalloproteases like ADAMDEC1. Other LRP-interacting proteins are lipoprotein lipase (LPL) and t-PA. For an association study, 165 thrombotic patients with high FVIII levels (from the MAISTHRO, i.e. Main-Isar-thrombosis register) were included. All patients with known causes for high FVIII levels had been previously excluded. The patients were compared with 214 healthy blood donors. Polymorphisms with usually a minor allele frequency > 5 %, i.e. 24 SNPs and two insertion/deletion polymorphisms of LPL gene, eight SNPs of the t-PA gene, and five SNPs of the ADAMDEC1 gene, were analyzed. Haplotype differences were calculated using PHASE. A new polymorphism in intron 7 of the t-PA gene with a minor allele frequency of 2.2% was identified. Analysis of each SNP by the Cochrane-Armitage trend test did not show any significant association between genotype and disease status. Interestingly, the ADAMDEC1 haplotype (rs12674766, rs10087305, rs2291577, rs2291578, rs3765124) differed between cases and controls (p=0.04). In particular, the TGTGG haplotype showed a difference. In conclusion, the ADAMDEC 1 haplotype may indicate an underlying mechanism for high FVIII levels. The only moderate linkage disequilibrium may be due to a possible causal polymorphism in distant introns or the promoter region against a polygenic background.

Keywords

Factor VIII - inherited thrombophilia - metalloprotease - venous thromboembolism

Volltext

Referenzen

References
1 Koster T, Blann AD, Briet E. et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-155.
2 Kyrle PA, Minar E, Hirschl M. et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343: 457-462.
3 Saenko EL, Yakhyaev AV, Mikhailenko I. et al. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism. J Biol Chem 1999; 274: 37685-37692.
4 Lenting PJ, Neels JG, van den Berg BM. et al. The light chain of factor VIII comprises a binding site for low-density lipoprotein receptor-related protein. J Biol Chem 1999; 274: 23734-23739.
5 Bovenschen N, Herz J, Grimbergen JM. et al. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency. Blood 2003; 101: 3933-3939.
6 Schambeck CM, Grossmann R, Zonnur S. et al. High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII. Thromb Haemost 2004; 92: 42-46.
7 Kamphuisen PW, Lensen R, Houwing-Duistermaat JJ. et al. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. Br J Haematol 2000; 109: 519-522.
8 Schambeck CM, Hinney K, Haubitz I. et al. Familial clustering of high factor VIII levels in patients with venous thromboembolism. Arterioscler Thromb Vasc Biol 2001; 21: 289-292.
9 Vormittag R, Bencur P, Ay C. et al. Low-density lipoprotein receptor-related protein1 polymorphism 663C>T affects clotting factor VIII activity and increases the risk of venous thromboembolism. J Thromb Haemost 2007; 5: 497-502.
10 Yepes M, Sandkvist M, Moore EG. et al. Tissuetype plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 2003; 112: 1533-1540.
11 Huovila AP, Turner AJ, Pelto-Huikko M. et al. Shedding light on ADAM metalloproteinases. Trends Biochem Sci 2005; 30: 413-422.
12 Berger M, Mattheisen M, Kulle B. et al. High factor VIII levels in venous thromboembolism show linkage to imprinted loci on chromosomes 5 and 11. Blood 2005; 105: 638-644.
13 Strickland DK, Ranganathan S. Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J Thromb Haemost 2003; 1: 1663-1670.
14 Strickland DK, Medved L. Low-density lipoprotein receptor-related protein (LRP)-mediated clearance of activated blood coagulation co-factors and proteases: clearance mechanism or regulation?. J Thromb Haemost 2006; 4: 1484-1486.
15 Quinn KA, Grimsley PG, Dai Y-P. et al. Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J Biol Chem 1997; 272: 23946-23951.
16 Quinn KA, Pye VJ, Dai YP. et al. Characterization of the soluble form of the low density lipoprotein receptor- related protein (LRP). Exp Cell Res 1999; 251: 433-441.
17 Rose-John S, Heinrich PC. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994; 300: 281-290.
18 von Arnim CA, Kinoshita A, Peltan ID. et al. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J Biol Chem 2005; 280: 17777-17785.
19 White JM. ADAMs: modulators of cell-cell and cell-matrix interactions. Current Opinion in Cell Biology 2003; 15: 598-606.
20 Bates EEM, Fridman WH, Mueller CGF. The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12. Immunogenetics 2002; 54: 96-105.
21 Mueller CG, Cremer I, Paulet PE. et al. Mannose receptor ligand-positive cells express the metalloprotease decysin in the B cell follicle. J Immunol 2001; 167: 5052-5060.